Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?

J Allergy Clin Immunol. 2020 Apr;145(4):1153-1156. doi: 10.1016/j.jaci.2019.10.021. Epub 2019 Nov 1.
No abstract available

Keywords: Food allergy; Institute for Clinical and Economic Review; US Food and Drug Administration Allergenic Products Advisory Committee; efficacy; management; peanut allergy; quality of life; safety; treatment.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academies and Institutes
  • Administration, Oral
  • Advisory Committees
  • Desensitization, Immunologic / methods*
  • Government Regulation
  • Humans
  • Peanut Hypersensitivity / immunology
  • Peanut Hypersensitivity / therapy*
  • Policy Making
  • United States
  • United States Food and Drug Administration